Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 6.

Journal Article

Benza, Raymond L., Corris, Paul A., Klinger, James R., Langleben, David, Naeije, Robert, Simonneau, Gerald, Ghofrani, Hossein-Ardeschir, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura, Thenappan, Thenappan ORCID: 0000-0002-6210-0467, Raina, Amresh, Meier, Christian, Busse, Dennis and Hoeper, Marius M. (2020). Identifying potential parameters associated with response to switching from a PDE5i to riociguat in RESPITE. Int. J. Cardiol., 317. S. 188 - 193. CLARE: ELSEVIER IRELAND LTD. ISSN 1874-1754

Bonderman, Diana, Pretsch, Ingrid, Steringer-Mascherbauer, Regina, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Tufaro, Caroline, Bojic, Andja, Lam, Carolyn S. P., Frey, Reiner, Kilama, Michael Ochan, Unger, Sigrun, Roessig, Lothar and Lang, Irene M. (2014). Acute Hemodynamic Effects of Riociguat in Patients With Pulmonary Hypertension Associated With Diastolic Heart Failure (DILATE-1). Chest, 146 (5). S. 1274 - 1286. AMSTERDAM: ELSEVIER SCIENCE BV. ISSN 0012-3692

Ghofrani, Hossein-Ardeschir, Grimminger, Friedrich ORCID: 0000-0001-8725-6276, Gruenig, Ekkehard, Huang, Yigao, Jansa, Pavel ORCID: 0000-0002-3711-7064, Jing, Zhi-Cheng ORCID: 0000-0003-0493-0929, Kilpatrick, David, Langleben, David, Rosenkranz, Stephan, Menezes, Flavia, Fritsch, Arno, Nikkho, Sylvia and Humbert, Marc ORCID: 0000-0003-0703-2892 (2016). Predictors of long-term outcomes in patients treated with riociguat for pulmonary arterial hypertension: data from the PATENT-2 open-label, randomised, long-term extension trial. Lancet Resp. Med., 4 (5). S. 361 - 372. OXFORD: ELSEVIER SCI LTD. ISSN 2213-2600

Ghofrani, Hossein-Ardeschir, Gruenig, Ekkehard, Jansa, Pavel ORCID: 0000-0002-3711-7064, Langleben, David, Rosenkranz, Stephan, Preston, Ioana R., Rahaghi, Franck, Sood, Namita, Busse, Dennis, Meier, Christian and Humbert, Marc (2020). Efficacy and safety of riociguat in combination therapy for patients with pulmonary arterial hypertension (PATENT studies). Pulm. Circ., 10 (3). THOUSAND OAKS: SAGE PUBLICATIONS INC. ISSN 2045-8940

Hoeper, Marius M., Simonneau, Gerald, Corris, Paul A., Ghofrani, Hossein-Ardeschir, Klinger, James R., Langleben, David, Naeije, Robert, Jansa, Pavel ORCID: 0000-0002-3711-7064, Rosenkranz, Stephan, Scelsi, Laura ORCID: 0000-0001-9409-691X, Gruenig, Ekkehard, Vizza, Carmine Dario, Chang, MiKyung, Colorado, Pablo, Meier, Christian, Busse, Dennis and Benza, Raymond L. (2017). RESPITE: switching to riociguat in pulmonary arterial hypertension patients with inadequate response to phosphodiesterase-5 inhibitors. Eur. Resp. J., 50 (3). SHEFFIELD: EUROPEAN RESPIRATORY SOC JOURNALS LTD. ISSN 1399-3003

McLaughlin, Vallerie V., Jansa, Pavel ORCID: 0000-0002-3711-7064, Nielsen-Kudsk, Jens E., Halank, Michael, Simonneau, Gerald, Gruenig, Ekkehard, Ulrich, Silvia ORCID: 0000-0002-5250-5022, Rosenkranz, Stephan, Gomez Sanchez, Miguel A., Pulido, Tomas, Pepke-Zaba, Joanna, Albert Barbera, Joan, Hoeper, Marius M., Vachiery, Jean-Luc, Lang, Irene, Carvalho, Francine, Meier, Christian, Mueller, Katharina, Nikkho, Sylvia and D'Armini, Andrea M. (2017). Riociguat in patients with chronic thromboembolic pulmonary hypertension: results from an early access study. BMC Pulm. Med., 17. LONDON: BMC. ISSN 1471-2466

This list was generated on Sat May 8 02:46:46 2021 CEST.